ARCHIVES

ImClone Offered C225 Deal To Seven Firms Prior To BMS

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Combined analysis moves Herceptin to adjuvant setting in breast cancer.

May 27, 2005

Charles Balch resigns as ASCO executive vice president; Joseph Bailes named interim EVP.

October 28, 2005

NCI Intramural Budget And List Of Highest-Funded Branches, Laboratories

April 21, 1995

Experts Raise Questions About Influential Swedish Trial Of Mammography Screening.

May 11, 2007

UC Breast Cancer ProgramTo Award $20 Million In Grants

December 16, 1994

Medicare Should Pay Routine Care For Patients in Trials: IOM.

January 7, 2000